Tradestie Institutional Equity Comparison Engine
RDY vs IFN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RDY Overall Edge
RDY Captures Institutional Edge (3โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, RDY trades at 31.6x Forward P/E with 9.1% operating margin (-1.5% YoY revenue) versus IFN at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, RDY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against IFN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
RDY
RDY 31.6x vs IFN N/M Fwd P/E
Growth & Margin Winner
RDY
Op Margin 9.1% vs N/A ยท YoY -1.5% vs N/A
Momentum & Technical Winner
RDY
1Y +6.0% vs -23.9% ยท 52W Pos 78% vs 26%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
RDY
NYSE
Dr. Reddy's Laboratories Limited American Depositary Shares
Pharmaceutical Preparations
$14.70
-0.27% 1D
Market Cap
$12.3B
1M Return
+12.47%
1Y Return
+5.98%
Forward P/E
31.6x
Unified AI Score
34.7 / 100
SELL
Tech 17.0
Fund 34.0
Flow 50.0
Mom 40.0
IFN
NYSE
The India Fund, Inc.
Institutional Equity
$11.48
+0.17% 1D
Market Cap
$593.5M
1M Return
+8.61%
1Y Return
-23.92%
Forward P/E
N/M
Unified AI Score
29.1 / 100
SELL
Tech 5.0
Fund 33.0
Flow 50.0
Mom 54.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
RDY +5.98%
IFN -23.92%
Spread: +29.9 pp (RDY Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
RDY TTM Op. Margin: 9.1%
IFN TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RDY vs IFN. Trailing 12-month operating profitability (RDY 9.1% vs IFN N/A) and valuation multiples (RDY 31.6x vs IFN N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | RDY | IFN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $12.3B | $593.5M | Larger Scale | RDY |
| Trailing P/E Ratio Valuation | 40.9x | N/M | Lower Multiple | RDY |
| Forward P/E Ratio Valuation | 31.6x | N/M | Lower Multiple | RDY |
| Revenue Growth (YoY) Growth | -1.5% | N/A | Higher Growth | RDY |
| Operating Margin (TTM) Profitability | 9.1% | N/A | Higher Margin | RDY |
| Net Profit Margin Profitability | 8.5% | N/A | Higher Margin | RDY |
| Return on Equity (ROE) Capital Efficiency | 7.3% | N/A | Higher ROE | RDY |
| 52-Week Range Position Momentum | 78% ($11โ$16) | 26% ($10โ$15) | Stronger Trend | RDY |
| Beta / 30D Volatility Risk Regime | 0.39ฮฒ ยท 24% Vol | 0.68ฮฒ ยท 20% Vol | Lower Realized Risk | IFN |
| Unified Institutional Score Composite Signal | 34.7 / 100 (SELL) | 29.1 / 100 (SELL) | Higher Composite | RDY |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full RDY vs IFN Buy Guide
RDY
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
IFN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither RDY nor IFN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.